These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9681820)

  • 1. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.
    Patel AS; Schechter GL; Wasilenko WJ; Somers KD
    Oncogene; 1998 Jun; 16(25):3227-32. PubMed ID: 9681820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortactin potentiates bone metastasis of breast cancer cells.
    Li Y; Tondravi M; Liu J; Smith E; Haudenschild CC; Kaczmarek M; Zhan X
    Cancer Res; 2001 Sep; 61(18):6906-11. PubMed ID: 11559568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein.
    Lin J; Liu J; Wang Y; Zhu J; Zhou K; Smith N; Zhan X
    Oncogene; 2005 Mar; 24(12):2059-66. PubMed ID: 15688017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
    Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD
    Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
    Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
    Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.
    Chuma M; Sakamoto M; Yasuda J; Fujii G; Nakanishi K; Tsuchiya A; Ohta T; Asaka M; Hirohashi S
    J Hepatol; 2004 Oct; 41(4):629-36. PubMed ID: 15464244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortactin regulates cell migration through activation of N-WASP.
    Kowalski JR; Egile C; Gil S; Snapper SB; Li R; Thomas SM
    J Cell Sci; 2005 Jan; 118(Pt 1):79-87. PubMed ID: 15585574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortactin affects cell migration by regulating intercellular adhesion and cell spreading.
    van Rossum AG; Moolenaar WH; Schuuring E
    Exp Cell Res; 2006 May; 312(9):1658-70. PubMed ID: 16527272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
    Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
    Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cortactin as putative cancer antigen.
    Lagarkova MA; Boitchenko VE; Mescheryakov AA; Kashkarova UA; Nedospasov SA
    Oncogene; 2000 Oct; 19(45):5204-7. PubMed ID: 11064458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG; Zhang X; Yoneda T; Yee D
    Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.
    Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR
    Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
    Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
    Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells.
    Kocher HM; Sandle J; Mirza TA; Li NF; Hart IR
    Gut; 2009 Feb; 58(2):271-84. PubMed ID: 18852256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer.
    Kudo Y; Ogawa I; Kitajima S; Kitagawa M; Kawai H; Gaffney PM; Miyauchi M; Takata T
    Cancer Res; 2006 Jul; 66(14):6928-35. PubMed ID: 16849536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.